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Laboratory diagnostics 
of emergency conditions 
associated with inborn 
errors of metabolism
ABSTRACT
Inborn errors of metabolism are a growing group of monogenic hereditary diseases whose pathogenesis may be accounted 
for by biochemical disorders. The great majority of these diseases may occur as a metabolic crisis at any period of life. For 
their adequate treatment, fast recognition of the cause of the metabolic disorder is necessary, as well as good collaboration 
of all health professionals involved in immediate patient healthcare. On the path to final diagnosis, it is advisable to consult 
specialised centres in order to select appropriate diagnostic tests and procedures.  
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Introduction
Inborn errors of metabolism (IEMs) are 
a consequence of biochemical altera-
tions originating in genes that result in 
the alteration of a protein. As the possi-
bility of mutations is extremely high, a 
variety of changes at the biochemical 
level is understandable, as well as a 
high variability of clinical data.  Taken 
individually, IEMs are highly infrequent 
but, taken as a whole, IEMs (of which 
over 550 have been described to date) 
can affect 1/500 newborn babies. The 
field of inborn errors of metabolism 
has been developing very fast over 
the past few years. New diseases 
have been detected, new diagnostic 
tests developed and novel treatment 
opportunities have been found. (1) 
Although IEMs have usually been con-
sidered as paediatric diseases, the 
fact that they can be present at any 
age represents a special challenge in 
general and paediatric practice. They 
are frequently characterised by acute, 
life-threatening crises that require an 
immediate and specific intervention. 
The development and prognosis of 
affected patients may depend on rapid 
and effective treatment, but the large 
number of genetic defects in various 
metabolic pathways makes it difficult 
to be familiar with all diagnostic strate-
gies and specific therapies. (2)
The diagnostic approach 
The fact that treatment is becoming 
available for an ever-increasing number 
of disorders from this group of diseases 
imposes the need for their early clinical 
recognition and for adequate labora-
tory diagnostics. Given their individual 
infrequency, most physicians and labo-
ratory professionals have limited expe-
rience in dealing with these diseases, 
so that their collaboration is of utmost 
importance. 
IEMs that occur with increased frequen-
cy in certain populations and are curable 
(but cannot be clinically recognised at 
an early stage), are included in newborn 
screening programmes (e.g. phenyl-
ketonuria, congenital hypothyroidism, 
leucinosis, homocystinuria, fatty acid 
beta-oxidation disorders, etc.). The tech-
nology of tandem mass spectrometry 
currently enables the diagnosis of more 
than 50 inherited metabolic diseases as 
early as in the newborn period (dried 
blood spot). Regrettably, most of these 
diseases are not treatable at present; 
and since diseases in the pre-sympto-
matic phase are also being detected, 
such an approach to diagnostics opens 
a number of ethical doubts that each 
community must solve. (3) 
Another approach to the diagnostics of 
these rare diseases implies the labora-
tory management of symptomatic pati-
ents (so-called selective screening). The 
majority of diseases are detected in this 
process in the manner that the possibi-
lity of an inherited metabolic disorder is 
suspected on the basis of typical data 
from the patient’s medical history, sta-
tus and basic laboratory test results. 
Subsequently, certain specific metabolic 
analyses are performed in suspected 
patients in order to confirm/reject the 
suspicion as soon as possible. 
Metabolic crises
The clinical symptoms of the most 
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important metabolic diseases can be 
classified according to their pathop-
hysiological background as being of 
“intoxication type, energy deficiency 
type, diseases due to limited intole-
rance of starvation, neurotransmission 
disorders, and other acute metabolic 
disorders”. A large number of these 
diseases manifest themselves with 
suddenly occurring life-threatening 
conditions, or so-called metabolic cri-
ses. Metabolic crises frequently occur 
as early as in the first days of life and 
may also be explained as newborn 
sepsis. Circumstances that can pro-
voke acute metabolic attacks include 
prolonged starvation, stressful situa-
tions, fever, intercurrent illness, and 
these may even manifest for the first 
time at an adult age. (4) 
In order to provide urgent and adequate 
treatment of patients with a metabolic 
crisis, inborn errors of metabolism sho-
uld be suspected and assessed (based 
on metabolic test results) in order to 
be classified among one of the above-
mentioned groups of disorders.  
Disorders that give rise to intoxication 
lead to an acute or progressive intoxi-
cation from the accumulation of toxic 
compounds proximal to the metabolic 
block. This group consists of IEMs 
of amino acid catabolism (leucino-
sys, tyrosinemia, etc.), most organic 
acidurias (methylmalonic, propionic, 
isovaleric, etc.), congenital urea cycle 
defects, glucose intolerances (galac-
tosemia, hereditary fructose intole-
rance), metal intoxication and porp-
hyrias. All the conditions in this group 
are characterised by a symptom-free 
interval and clinical signs of “intoxica-
tion”, which may be acute (vomiting, 
coma, liver failure, thromboembolic 
complications, etc.) or chronic (fai-
lure to thrive, developmental delay, 
ectopia lentis, cardiomyopathy, etc.). 
Most of these disorders are treatable 
and require the emergency removal 
of the toxin by special diets, extra-
corporeal procedures or “cleansing” 
drugs (carnitine, sodium benzoate, 
penicillamine, etc.).
Disorders involving energy metabolism 
comprise IEMs with symptoms due at 
least partly to a deficiency in energy 
production or utilisation within the liver, 
myocardium, muscle, brain or other 
tissues. They encompass congenital 
lactic acidemias (defects of the pyru-
vate transporter, pyruvate carboxylase, 
pyruvate dehydrogenase and the Krebs 
cycle), mitochondrial respiratory chain 
disorders, fatty acid oxidation and keto-
ne body defects, disorders of glycolysis 
and glycogen metabolism. Common 
symptoms in this group include hypo-
glycemia, hyperlactatemia, hepatome-
galy, severe generalised hypotonia, 
myopathy, cardiomyopathy, failure to 
thrive, cardiac failure, circulatory collap-
se, sudden unexpected death in infan-
cy and brain involvement. 
Diseases caused by starvation into-
lerance (hepatic glycogenoses, glu-
coneogenesis disorders, some fatty 
acid beta-oxidation disorders, disor-
ders of carnitine cycle, ketogenesis and 
ketolysis) are characterised by hypogl-
ycemia after relatively brief starvation. 
The period of starvation necessary for 
symptoms to manifest varies depen-
ding on disease and a number of other 
factors.   
Although pathophysiology is somew-
hat different from the inborn errors of 
neurotransmitter synthesis and catabo-
lism (monoamines, GABA and glycine), 
the inborn errors of amino acid synt-
hesis (serine, glutamine) can also be 
included in this group. These disorders 
manifest themselves as acute encep-
halopathy with epilepsy, with treatable 
convulsions. (5)
Emergency laboratory 
tests in an acute metabolic 
crisis 
After clinically suspecting an IEM, 
samples for laboratory tests should be 
urgently collected, if possible during the 
metabolic crisis. Efforts should be made 
to perform sampling prior to infusion (of 
glucose, carnitine, etc.) because such 
samples provide the most information 
since they are often the only source of 
diagnostically significant metabolites.   
In addition to basic laboratory tests 
(blood count, C-reactive protein, elec-
trolytes, aminotransferases, creatine 
kinase, urea, creatinine, urates, basic 
coagulation tests), basic metabolic 
tests should also be carried out  (acid-
base status, glucose, ammonium, lac-
tate and methyketones). The results of 
these tests may indicate the presence 
of a metabolic disorder to a physician, 
yet they do not reveal the cause of the 
disorder. For a clinician, it is of utmost 
importance to receive the results of 
these tests as urgently as possible (wit-
hin 60 minutes) in order to manage the 
patient before the basic cause of meta-
bolic crisis is detected. (6,7) 
The above-mentioned tests are part of 
the laboratory test panel of all general 
hospitals. 
A further step in the search for the cause 
of the metabolic crisis is the interpretati-
on of results of specific metabolic tests, 
i.e. amino acid concentration in pla-
sma and/or cerebrospinal fluid, organic 
acids in urine, total and free carnitine in 
plasma and acyl-carnitine profile from 
a dried blood spot on filter paper and/
or plasma.
These specific metabolic tests are ava-
ilable only in laboratories dealing with 
diagnostics of inborn errors of meta-
bolism because specific equipment 
is needed for their implementation, as 
well as adequately educated medical 
biochemistry specialists. In a large 
number of cases, it is also necessary 
to perform a whole series of other spe-
cific tests on the pathway to a final 
diagnosis (e. g. biotinidase, galactose, 
homocysteine, creatine, neurotransmi-
tters, free fatty acids, glutation, porp-
hyrins, pyrimidines, etc.). Methods to 
perform these tests are often available 
only in specialist diagnostic centres. 
These tests should therefore be uti-
lised economically after performing 
basic metabolic analyses, considering 
clinical data and providing specialist 
patient management. Due to a num-
ber of specificities that accompany 
the carrying out of most confirmation 
tests, it is advisable to consult spe-
cialist centres in order to additionally 
ensure correct sampling, storage and 
transport of adequate samples. 
It is important to mention that in cases 
when a patient cannot be cured, every 
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effort should be made to collect and 
adequately store samples of plasma, 
urine and EDTA whole blood for DNA 
isolation, as well as to perform biopsy 
of the skin and, when necessary, other 
tissues. Only such an approach may 
enable the establishment of a post-
mortem diagnosis and provide other 
members of the family of a patient 
diagnosed with IEM with this informa-
tion. (8)
Conclusion
However, although they are being incre-
asingly recognised, IEM remain rare. 
They should be considered in parallel 
with other more common conditions 
and it should be remembered that an 
IEM can be present at any age. Satis-
factory care for acutely compromised 
IEM patients is only possible through 
teamwork that involves personnel in 
emergency admission wards, laborato-
ries and centres specialised for IEM. In 
this regard, algorithms for procedures 
in certain situations that are prepared in 
advance may be of substantial aid.  
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